Post #41

An MIT professor who invested early in Moderna is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine. Moderna’s shares have more than quadrupled this year, surging 20% on Monday alone. https://bloom.bg/2WHMsO5 The results should be viewed with caution as they stem from a small, early study designed to look at the safety of the shot in human volunteers. A larger test is being planned. It’s hardly the only coronavirus vaccine being developed right now. Get the full picture here: https://bloom.bg/2AHO567